MeSH term
Frequency | Condition_Probility | Animals | 40 | 0.0 |
Cell Line | 10 | 0.0 |
Humans | 64 | 0.0 |
Lymphocyte Activation/*immunology | 3 | 0.0 |
Mice | 30 | 0.0 |
T-Lymphocytes/*immunology | 10 | 0.0 |
Antigen Presentation | 2 | 0.0 |
Antigens, Differentiation, T-Lymphocyte/physiology | 2 | 2.0 |
Immunohistochemistry | 2 | 0.0 |
Mice, Inbred C57BL | 6 | 0.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 46 | 0.0 |
Antigens, CD28/*physiology | 2 | 2.0 |
*Blood Proteins | 3 | 3.0 |
*Immunoconjugates | 12 | 3.0 |
Peptides/physiology | 2 | 5.0 |
Research Support, U.S. Gov't, P.H.S. | 16 | 0.0 |
Amino Acid Sequence | 12 | 0.0 |
Ligands | 11 | 0.0 |
Molecular Sequence Data | 15 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Sequence Homology, Amino Acid | 6 | 0.0 |
DNA, Complementary/genetics | 3 | 0.0 |
Signal Transduction | 4 | 0.0 |
Alleles | 4 | 0.0 |
Antigens, CD28/genetics | 3 | 15.0 |
Antigens, Differentiation/genetics | 4 | 12.0 |
Antigens, Differentiation, T-Lymphocyte/*genetics | 10 | 18.0 |
Base Sequence | 8 | 0.0 |
Exons | 2 | 0.0 |
Finland | 2 | 0.0 |
Gene Frequency | 4 | 0.0 |
Introns | 2 | 0.0 |
Linkage (Genetics) | 2 | 0.0 |
T-Lymphocytes/immunology | 6 | 0.0 |
Antigens, CD28/metabolism | 2 | 2.0 |
Antigens, Differentiation/metabolism | 2 | 1.0 |
Antigens, CD28/*genetics | 4 | 19.0 |
Antigens, Differentiation/*genetics | 5 | 3.0 |
Microsatellite Repeats/genetics | 2 | 0.0 |
Polymorphism, Genetic | 2 | 0.0 |
*Chromosome Mapping | 3 | 0.0 |
Genetic Predisposition to Disease | 4 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Diabetes Mellitus, Type 1/*genetics | 3 | 1.0 |
Female | 15 | 0.0 |
Japan | 2 | 0.0 |
Linkage Disequilibrium | 2 | 0.0 |
Male | 14 | 0.0 |
*Polymorphism, Genetic | 4 | 0.0 |
DNA Primers | 3 | 0.0 |
Dendritic Cells/cytology/*immunology | 2 | 3.0 |
Antigens, Differentiation, T-Lymphocyte/genetics/*immunology | 3 | 16.0 |
Cytokines/biosynthesis | 8 | 1.0 |
Gene Expression | 4 | 0.0 |
Mice, Inbred BALB C | 9 | 0.0 |
Rats | 4 | 0.0 |
Th1 Cells/*immunology | 2 | 1.0 |
Th2 Cells/*immunology | 3 | 2.0 |
Cells, Cultured | 4 | 0.0 |
Gene Expression Regulation/*immunology | 2 | 1.0 |
Immunophenotyping | 2 | 0.0 |
Mice, Knockout | 4 | 0.0 |
Protein Biosynthesis | 3 | 0.0 |
Spleen/cytology/immunology/metabolism | 2 | 12.0 |
B-Lymphocytes/*immunology | 4 | 0.0 |
Drug Administration Schedule | 2 | 0.0 |
Injections, Intraperitoneal | 2 | 1.0 |
Cytokines/antagonists & inhibitors/biosynthesis | 2 | 11.0 |
Down-Regulation/immunology | 2 | 2.0 |
Lymphocyte Activation/immunology | 3 | 0.0 |
Signal Transduction/immunology | 4 | 1.0 |
Th2 Cells/immunology/metabolism | 2 | 5.0 |
Up-Regulation/immunology | 2 | 1.0 |
Cloning, Molecular | 6 | 0.0 |
Comparative Study | 5 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Antigens, Differentiation, T-Lymphocyte/genetics/*physiology | 2 | 22.0 |
CD4-Positive T-Lymphocytes/metabolism | 2 | 1.0 |
Chromosome Mapping | 5 | 0.0 |
Dimerization | 2 | 0.0 |
Glycosylation | 3 | 0.0 |
Germinal Center/cytology/immunology | 2 | 28.0 |
Immunoglobulin G/biosynthesis | 5 | 3.0 |
Immunoglobulin M/biosynthesis | 2 | 2.0 |
Immunologic Memory/immunology | 3 | 7.0 |
Antibodies, Monoclonal/immunology | 2 | 0.0 |
CHO Cells | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Antigens, CD28/*immunology | 4 | 2.0 |
Antigens, Differentiation/immunology | 3 | 2.0 |
Jurkat Cells | 2 | 0.0 |
Mice, Transgenic | 4 | 0.0 |
Flow Cytometry | 4 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
In Vitro | 3 | 0.0 |
Antibodies, Monoclonal/pharmacology | 3 | 0.0 |
Antigens, Differentiation, T-Lymphocyte/*metabolism | 4 | 3.0 |
Cell Division | 2 | 0.0 |
COS Cells | 2 | 0.0 |
Epitopes, T-Lymphocyte/immunology | 2 | 2.0 |
Lymphocyte Activation | 6 | 0.0 |
Protein Binding | 2 | 0.0 |
Antigens, Differentiation, T-Lymphocyte/genetics/*metabolism | 2 | 25.0 |
DNA, Complementary | 2 | 0.0 |
*Lymphocyte Activation | 4 | 0.0 |
Antigens, Differentiation, T-Lymphocyte/genetics | 2 | 6.0 |
Transfection | 2 | 0.0 |
Mice, Inbred NOD | 2 | 0.0 |
*Genetic Predisposition to Disease | 2 | 0.0 |
Antigens, Differentiation, T-Lymphocyte/*immunology | 3 | 1.0 |
Cell Differentiation/physiology | 2 | 0.0 |
Sensitivity and Specificity | 2 | 0.0 |
Coculture Techniques | 2 | 0.0 |
Receptors, Antigen, T-Cell/immunology | 2 | 1.0 |
Case-Control Studies | 3 | 0.0 |
Celiac Disease/*genetics | 2 | 7.0 |
Chromosomes, Human, Pair 2/*genetics | 3 | 1.0 |
Haplotypes/genetics | 2 | 0.0 |
Genotype | 4 | 0.0 |
Antigens, Differentiation, T-Lymphocyte/*genetics/metabolism | 2 | 33.0 |
Child | 3 | 0.0 |
Models, Immunological | 2 | 0.0 |
T-Lymphocytes/physiology | 2 | 1.0 |
Antigens, CD28/immunology | 2 | 1.0 |
Adult | 4 | 0.0 |
Middle Aged | 4 | 0.0 |
Interferon Type II/biosynthesis | 2 | 0.0 |
Adolescent | 4 | 0.0 |
